tiprankstipranks
Advertisement
Advertisement

ATOS Stock Latest News

Atossa Therapeutics’ Endoxifen shows breast cancer risk prevention in trial
The FlyAtossa Therapeutics’ Endoxifen shows breast cancer risk prevention in trial
11h ago
ATOS
Atossa Therapeutics says FDA grants RPD to (Z)-endoxifen to treat MAS
PremiumThe Fly
Atossa Therapeutics says FDA grants RPD to (Z)-endoxifen to treat MAS
3d ago
ATOS
Atossa: Patent De‑Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
PremiumRatings
Atossa: Patent De‑Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
20d ago
ATOS
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
PremiumCompany Announcements
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
21d ago
8K
ATOS
Atossa Therapeutics target adjusted to $25 from $7 at H.C. Wainwright
PremiumThe Fly
Atossa Therapeutics target adjusted to $25 from $7 at H.C. Wainwright
1M ago
ATOS
Atossa Therapeutics reports 2025 EPS ($4.04), consensus ($3.91)
PremiumThe FlyAtossa Therapeutics reports 2025 EPS ($4.04), consensus ($3.91)
1M ago
ATOS
Atossa Therapeutics announces addition of two biopharma executives to team
Premium
The Fly
Atossa Therapeutics announces addition of two biopharma executives to team
2M ago
ATOS
VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26
Premium
Market News
VTI ETF Inflows Hold Steady Despite AI Sell-Off – 2/24/26
2M ago
L
CLB
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26
2M ago
CLB
IMA
Atossa Therapeutics Launches New $50 Million ATM Program
PremiumCompany Announcements
Atossa Therapeutics Launches New $50 Million ATM Program
3M ago
8K
ATOS
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/20/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/20/26
3M ago
L
CLB
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/19/26
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/19/26
3M ago
L
CLB
Atossa Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk
PremiumCompany AnnouncementsAtossa Therapeutics Regains Nasdaq Compliance, Avoids Delisting Risk
3M ago
8K
ATOS
Atossa Therapeutics price target lowered to $10 from $35 at Craig-Hallum
Premium
The Fly
Atossa Therapeutics price target lowered to $10 from $35 at Craig-Hallum
3M ago
ATOS
Atossa Therapeutics Issues 2026 Outlook and Strategic Update
Premium
Company Announcements
Atossa Therapeutics Issues 2026 Outlook and Strategic Update
3M ago
8K
ATOS
Atossa Therapeutics: Strategic Endoxifen Opportunity in DMD and PRV Creates Buy-Rated Upside at Disconnected Valuation
PremiumRatings
Atossa Therapeutics: Strategic Endoxifen Opportunity in DMD and PRV Creates Buy-Rated Upside at Disconnected Valuation
3M ago
ATOS
Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested
3M ago
PBM
AREB
Atossa Genetics trading halted, news pending
PremiumThe Fly
Atossa Genetics trading halted, news pending
3M ago
ATOS
Atossa Therapeutics Sets 15-for-1 Reverse Stock Split
PremiumCompany Announcements
Atossa Therapeutics Sets 15-for-1 Reverse Stock Split
3M ago
8K
ATOS
Atossa Therapeutics: FDA grants orphan designation to (Z)-endoxifen
PremiumThe FlyAtossa Therapeutics: FDA grants orphan designation to (Z)-endoxifen
4M ago
ATOS
FDA grants Atossa Therapeutics orphan drug designation for (Z)-endoxifen
Premium
The Fly
FDA grants Atossa Therapeutics orphan drug designation for (Z)-endoxifen
4M ago
ATOS
Atossa Therapeutics outlines strategy for lead (Z)-Endoxifen program
Premium
Company Announcements
Atossa Therapeutics outlines strategy for lead (Z)-Endoxifen program
4M ago
8K
ATOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >